ID,name ,description,leaf,PageRefs,type ,title
Table_14-3.01,Table 14-3.01,Primary Endpoint Analysis: ADAS-Cog - Summary at Week 24 - LOCF (Efficacy Population),CSR,2,PhysicalRef,Table 14-3.01
Table_14-5.02,Table 14-5.02,Incidence of Treatment Emergent Serious Adverse Events by Treatment Group,CSR,3,PhysicalRef,Table 14-5.02
